These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
937 related articles for article (PubMed ID: 9015217)
1. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217 [TBL] [Abstract][Full Text] [Related]
2. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin. Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587 [TBL] [Abstract][Full Text] [Related]
4. Physiologic role of TPO in thrombopoiesis. Miyazaki H Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213 [TBL] [Abstract][Full Text] [Related]
5. Megakaryocytopoiesis in vitro: from the stem cells' perspective. Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217 [TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin: biology and clinical potentials. Miyazaki H; Kato T Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146 [TBL] [Abstract][Full Text] [Related]
7. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro. Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788 [TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
9. A simple and quantitative liquid culture system to measure megakaryocyte growth using highly purified CFU-MK. Miyazaki H; Horie K; Shimada Y; Kokubo A; Maeda E; Inoue H; Kato T Exp Hematol; 1995 Oct; 23(11):1224-8. PubMed ID: 7556534 [TBL] [Abstract][Full Text] [Related]
10. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin. Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619 [TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant interleukin-6 and thrombopoietin on isolated guinea pig bone marrow megakaryocyte protein phosphorylation and proplatelet formation. Leven RM; Clark B; Tablin F Blood Cells Mol Dis; 1997 Aug; 23(2):252-68. PubMed ID: 9410469 [TBL] [Abstract][Full Text] [Related]
12. Compared effects of Mpl ligand and other cytokines on human MK differentiation. Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176 [TBL] [Abstract][Full Text] [Related]
14. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa. Miyazaki H; Inoue H; Yanagida M; Horie K; Mikayama T; Ohashi H; Nishikawa M; Suzuki T; Sudo T Exp Hematol; 1992 Aug; 20(7):855-61. PubMed ID: 1628703 [TBL] [Abstract][Full Text] [Related]
15. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions. Cardier JE; Erickson-Miller CL; Murphy MJ Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112 [TBL] [Abstract][Full Text] [Related]
16. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes. Straneva JE; Briddell RA; McDonald TP; Yang HH; Hoffman R Exp Hematol; 1989 Dec; 17(11):1122-7. PubMed ID: 2684680 [TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Schattner M; Lefebvre P; Mingolelli SS; Goolsby CL; Rademaker A; White JG; Foster D; Green D; Cohen I Stem Cells; 1996 Mar; 14(2):207-14. PubMed ID: 8991540 [TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. Cheng L; Qasba P; Vanguri P; Thiede MA J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234 [TBL] [Abstract][Full Text] [Related]
19. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis. van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]